Use of multivariate analysis to suggest a new molecular classification of colorectal cancer

Journal of Pathology

Volumn 229, Issue 3, 2013, Pages 441-448

  Domingo, Enric ^a   Ramamoorthy, Rajarajan ^a,b   Oukrif, Dahmane ^c   Rosmarin, Daniel ^a,d   Presz, Michal ^d   Wang, Haitao ^d   Pulker, Hannah ^a,e   Lockstone, Helen ^a   Hveem, Tarjei ^f,g   Cranston, Treena ^e   Danielsen, Havard ^f,g   Novelli, Marco ^c   Davidson, Brian ^b   Xu, Zheng Zhou ^h   Molloy, Peter ^h   Johnstone, Elaine ^d   Holmes, Christopher ^d   Midgley, Rachel ^d   Kerr, David ⁱ   Sieber, Oliver ^j   Tomlinson, Ian ^a   more..

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

^c UNIVERSITY COLLEGE HOSPITAL   (United Kingdom)

^d UNIVERSITY OF OXFORD   (United Kingdom)

^e CHURCHILL HOSPITAL   (United Kingdom)

^f OSLO UNIVERSITY HOSPITAL   (Norway)

^g UNIVERSITY OF OSLO   (Norway)

^h CSIRO   (Australia)

ⁱ UNIVERSITY OF OXFORD   (United Kingdom)

^j OLIVIA NEWTON JOHN CANCER RESEARCH INSTITUTE   (Australia)

more..

Author keywords

clinico pathological associations; colorectal cancer; genetic pathways; molecular classification; prognostic markers; somatic mutations

Indexed keywords

B RAF KINASE; PHOSPHATIDYLINOSITOL 4,5 BISPHOSPHATE 3 KINASE; PHOSPHATIDYLINOSITOL 4,5 BISPHOSPHATE 3 KINASE CATALYTIC SUBUNIT ALPHA; PROTEIN P53; ROFECOXIB; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; BAYES THEOREM; CANCER CLASSIFICATION; CANCER LOCALIZATION; CANCER STAGING; CHROMOSOMAL INSTABILITY; CLUSTER ANALYSIS; COLORECTAL CANCER; CORRELATION ANALYSIS; DISEASE FREE SURVIVAL; FEMALE; GENETIC SCREENING; HUMAN; HUMAN TISSUE; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; MICROSATELLITE INSTABILITY; MOLECULAR GENETICS; MULTIVARIATE ANALYSIS; MUTATIONAL ANALYSIS; ONCOGENE K RAS; ONCOGENE N RAS; PRIORITY JOURNAL; PROGNOSIS; SEX DIFFERENCE; SOMATIC MUTATION; TUMOR DIFFERENTIATION; WILD TYPE;

ADULT; AGED; AGED, 80 AND OVER; CHROMOSOMAL INSTABILITY; COLORECTAL NEOPLASMS; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; MALE; MICROSATELLITE INSTABILITY; MIDDLE AGED; MOLECULAR DIAGNOSTIC TECHNIQUES; MULTIVARIATE ANALYSIS; MUTATION; NEOPLASM PROTEINS; NEOPLASM STAGING; PHOSPHATIDYLINOSITOL 3-KINASES; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS B-RAF; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RAS PROTEINS; SEX FACTORS; SUCCINIMIDES; TUMOR MARKERS, BIOLOGICAL; TUMOR SUPPRESSOR PROTEIN P53;

EID: 84872921463     PISSN: 00223417     EISSN: 10969896     Source Type: Journal    
DOI: 10.1002/path.4139     Document Type: Article

References (31)

1. Lengauer C, Kinzler KW, Vogelstein B,. Genetic instability in colorectal cancers. Nature 1997; 386: 623-627. (Pubitemid 27175430)
2. Ionov Y, Peinado MA, Malkhosyan S, et al,. Ubiquitous somatic mutations in simple repeated sequences reveal a new mechanism for colonic carcinogenesis. Nature 1993; 363: 558-561. (Pubitemid 23186645)
3. Walther A, Johnstone E, Swanton C, et al,. Genetic prognostic and predictive markers in colorectal cancer. Nat Rev Cancer 2009; 9: 489-499.
4. Sinicrope FA, Rego RL, Halling KC, et al,. Prognostic impact of microsatellite instability and DNA ploidy in human colon carcinoma patients. Gastroenterology 2006; 131: 729-737. (Pubitemid 44307064)
5. Toyota M, Ahuja N, Ohe-Toyota M, et al,. CpG island methylator phenotype in colorectal cancer. Proc Natl Acad Sci USA 1999; 96: 8681-8686. (Pubitemid 29354851)
6. Weisenberger DJ, Siegmund KD, Campan M, et al,. CpG island methylator phenotype underlies sporadic microsatellite instability and is tightly associated with BRAF mutation in colorectal cancer. Nat Genet 2006; 38: 787-793. (Pubitemid 43980599)
7. Peinado M, Fernandezrenart M, Capella G, et al,. Mutations in the p53 suppressor gene do not correlate with C-k-ras oncogene mutations in colorectal cancer. Int J Oncol 1993; 2: 123-134. (Pubitemid 23043330)
8. Smith G, Carey FA, Beattie J, et al,. Mutations in APC, Kirsten-ras, and p53-alternative genetic pathways to colorectal cancer. Proc Natl Acad Sci USA 2002; 99: 9433-9438. (Pubitemid 34764631)
9. Iacopetta B., TP53 mutation in colorectal cancer. Hum Mut 2003; 21: 271-276. (Pubitemid 36292968)
10. Jass JR,. Classification of colorectal cancer based on correlation of clinical, morphological and molecular features. Histopathology 2007; 50: 113-130. (Pubitemid 44953403)
11. Ostwald C, Linnebacher M, Weirich V, Prall F,. Chromosomally and microsatellite stable colorectal carcinomas without the CpG island methylator phenotype in a molecular classification. Int J Oncol 2009; 35: 321-327.
12. Rowan A, Halford S, Gaasenbeek M, et al,. Refining molecular analysis in the pathways of colorectal carcinogenesis. Clin Gastro Hepatol 2005; 3: 1115-1123. (Pubitemid 41565378)
13. Midgley RS, McConkey CC, Johnstone EC, et al,. Phase III randomized trial assessing rofecoxib in the adjuvant setting of colorectal cancer: final results of the VICTOR trial. J Clin Oncol 2010; 28: 4575-4580.
14. Samuels Y, Wang Z, Bardelli A, et al,. High frequency of mutations of the PIK3CA gene in human cancers. Science 2004; 304: 554. (Pubitemid 38541907)
15. Segditsas S, Sieber OM, Rowan A, et al,. Promoter hypermethylation leads to decreased APC mRNA expression in familial polyposis and sporadic colorectal tumours, but does not substitute for truncating mutations. Exp Mol Pathol 2008; 85: 201-206.
16. Vaughn CP, Zobell SD, Furtado LV, et al,. Frequency of KRAS, BRAF, and NRAS mutations in colorectal cancer. Genes Chrom Cancer 2011; 50: 307-312.
17. Wood LD, Parsons DW, Jones S, et al,. The genomic landscapes of human breast and colorectal cancers. Science 2007; 318: 1108-1113. (Pubitemid 350134889)
18. Esteller M, Hamilton SR, Burger PC, et al,. Inactivation of the DNA repair gene O6-methylguanine-DNA methyltransferase by promoter hypermethylation is a common event in primary human neoplasia. Cancer Res 1999; 59: 793-797. (Pubitemid 29086728)
19. Jones AM, Douglas EJ, Halford SE, et al,. Array-CGH analysis of microsatellite-stable, near-diploid bowel cancers and comparison with other types of colorectal carcinoma. Oncogene 2005; 24: 118-129. (Pubitemid 40143871)
20. Calistri D, Rengucci C, Seymour I, et al,. Mutation analysis of p53, K-ras, and BRAF genes in colorectal cancer progression. J Cell Physiol 2005; 204: 484-488. (Pubitemid 40934643)
21. De Bruijn MT, Raats DAE, Tol J, et al,. Combined KRAS and TP53 mutation status is not predictive in CAPOX-treated metastatic colorectal cancer. Anticancer Res; 31: 1379-1385.
22. Giaretti W, Venesio T, Sciutto A, et al,. Near-diploid and near-triploid human sporadic colorectal adenocarcinomas differ for KRAS2 and TP53 mutational status. Genes Chrom Cancer 2003; 37: 207-213. (Pubitemid 36529789)
23. Reid JF, Gariboldi M, Sokolova V, et al,. Integrative approach for prioritizing cancer genes in sporadic colon cancer. Genes Chrom Cancer 2009; 48: 953-962.
24. Samowitz WS, Slattery ML, Sweeney C, et al,. APC mutations and other genetic and epigenetic changes in colon cancer. Mol Can Res 2007; 5: 165-170. (Pubitemid 46423997)
25. Suehiro Y, Wong CW, Chirieac LR, et al,. Epigenetic-genetic interactions in the APC/WNT, RAS/RAF, and P53 pathways in colorectal carcinoma. Clin Can Res 2008; 14: 2560-2569.
26. Samowitz WS, Sweeney C, Herrick J, et al,. Poor survival associated with the BRAF V600E mutation in microsatellite-stable colon cancers. Cancer Res 2005; 65: 6063-6069.
27. Vogelstein B, Fearon ER, Hamilton SR, et al,. Genetic alterations during colorectal tumor development. N Eng J Med 1988; 319: 525-532.
28. Bass AJ, Lawrence MS, Brace LE, et al,. Genomic sequencing of colorectal adenocarcinomas identifies a recurrent VTI1A-TCF7L2 fusion. Nat Genet 2011; 43: 964-968.
29. Rajagopalan H, Jallepalli PV, Rago C, et al,. Inactivation of hCDC4 can cause chromosomal instability. Nature 2004; 428: 77-81. (Pubitemid 38332360)
30. Hutchins G, Southward K, Handley K, et al,. Value of mismatch repair, KRAS, and BRAF mutations in predicting recurrence and benefits from chemotherapy in colorectal cancer. J Clin Oncol 2011; 29: 1261-1270.
31. Cancer Genome Atlas Network,. Comprehensive molecular characterization of human colon and rectal cancer. Nature 2012; 487: 330-337.